Sio Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,972
Closed -$102K 64
2022
Q3
$102K Sell
12,972
-32,350
-71% -$535K 0.04% 43
2022
Q2
$952K Hold
45,322
0.38% 43
2022
Q1
$1.7M Hold
45,322
0.69% 41
2021
Q4
$2.55M Hold
45,322
0.78% 34
2021
Q3
$3.27M Buy
45,322
+1,887
+4% +$144K 1.05% 31
2021
Q2
$4.16M Buy
43,435
+23,750
+121% +$2.62M 1.13% 35
2021
Q1
$2.91M Buy
19,685
+5,000
+34% +$906K 0.61% 53
2020
Q4
$2.05M Sell
14,685
-534
-4% -$86.5K 0.45% 67
2020
Q3
$2.31M Buy
15,219
+6,249
+70% +$1.02M 0.51% 54
2020
Q2
$1.57M Buy
+8,970
New +$1.5M 0.49% 54

Other funds holding NBSE